SEP 11, 2026 · JOURNAL ARTICLE
Beyond pCR Prediction: Subtype-Specific Artificial Intelligence for Treatment Tailoring in Breast Cancer Neoadjuvant Therapy
Cancers
A systematic review of 102 AI prediction studies showing that most lack external validation, prospective evidence, or workflow integration; none demonstrate interventional benefit for treatment tailoring in breast cancer neoadjuvant therapy.
Reported
Studies at L1 (internal validatio…43
Studies at L2 (external validatio…53
Studies at L3 (prospective observ…6